As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...
Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...
The National Community Pharmacists Association (NPCA) is warning the feds that independent pharmacists are likely to face ...
The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...
Zacks.com on MSN13d
FTC Report Reveals PBM Practices Impacting Competition and Drug CostsThe FTC study examines the practices of PBMs to ensure fair competition and transparency. The FTC found that from 2017 to 2022, the three big PBMs imposed substantial price markups on 51 specialty ...
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
Complex PBM money channels “make it hard to build ... and soon hopes to have a sort of “private reserve” of 70 to 80 products that it can make on short notice if they go into shortage ...
UnitedHealth Group (NYSE:UNH), a leading diversified healthcare company with a substantial market capitalization of $469.7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback